You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Pens Articles
Popular Pens Articles
Highly Recommended Pens Articles
Send a link to this page to your friends and colleagues.
Novo Nordisk, of Princeton, New Jersey, has received approval from the U.S. Food and Drug Administration for a new insulin delivery system with a special feature and design.
The colorful NovoPen Junior, an extension of the company's NovoPen line, delivers 1 to 35 units of insulin in half-unit dose increments. It was designed for children and teenagers on insulin therapy, who typically use smaller amounts of insulin, and for adults who need the flexibility to fine-tune their insulin dosages, according to a news release from Novo Nordisk.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.